Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Clin Infect Dis ; 54(10): 1448-54, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22474223

RESUMO

BACKGROUND: Systemic disease due to shigellae is associated with human immunodeficiency virus (HIV), malnutrition, and other immunosuppressed states. We examined the clinical and microbiologic characteristics of systemic shigellosis in South Africa, where rates of HIV infection are high. METHODS: From 2003 to 2009, 429 cases of invasive shigellosis were identified through national laboratory-based surveillance. At selected sites, additional information was captured on HIV serostatus and outcome. Isolates were serotyped and antimicrobial susceptibility testing performed. RESULTS: Most cases of systemic shigellosis were diagnosed on blood culture (408 of 429 cases; 95%). HIV prevalence was 67% (80 of 120 cases), highest in patients aged 5-54 years, and higher among females (55 of 70 cases; 79%) compared with males (25 of 48 cases; 52%; P = .002). HIV-infected people were 4.1 times more likely to die than HIV-uninfected cases (case-fatality ratio, 29 of 78 HIV-infected people [37%] vs 5 of 40 HIV-uninfected people [13%]; P = .008; 95% confidence interval [CI], 1.5-11.8). The commonest serotype was Shigella flexneri 2a (89 of 292 serotypes [30.5%]). Pentavalent resistance occurred in 120 of 292 isolates (41.1%). There was no difference in multidrug resistance between HIV-infected patients (33 of 71 [46%]) and uninfected patients (12 of 33 [36%]; 95% CI, .65--3.55). CONCLUSIONS: Systemic shigellosis is associated with HIV-infected patients, primarily in older girls and women, potentially due to the burden of caring for sick children in the home; interventions need to be targeted here. Death rates are higher in HIV-infected versus uninfected individuals.


Assuntos
Bacteriemia/epidemiologia , Disenteria Bacilar/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/farmacologia , Bacteriemia/microbiologia , Criança , Pré-Escolar , Disenteria Bacilar/microbiologia , Feminino , Infecções por HIV/complicações , Humanos , Hospedeiro Imunocomprometido , Lactente , Recém-Nascido , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Shigella/classificação , Shigella/efeitos dos fármacos , Shigella/isolamento & purificação , África do Sul/epidemiologia , Adulto Jovem
2.
Clin Infect Dis ; 42(11): e95-8, 2006 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-16652304

RESUMO

Four sequential extended-spectrum beta -lactamase-producing isolates of Klebsiella pneumoniae were obtained from a patient after treatment with ertapenem and cultured. The first and fourth isolates were susceptible to ertapenem, whereas the second and third were resistant. All 4 isolates belonged to the same strain and produced a group 1 CTX-M enzyme; additionally, the resistant isolates had lost a porin.


Assuntos
Klebsiella pneumoniae/efeitos dos fármacos , Klebsiella pneumoniae/enzimologia , Pneumonia Bacteriana/microbiologia , Resistência beta-Lactâmica , beta-Lactamases/metabolismo , beta-Lactamas/farmacologia , Idoso de 80 Anos ou mais , Antibacterianos/farmacologia , Ertapenem , Humanos , Infecções por Klebsiella/microbiologia , Masculino , Testes de Sensibilidade Microbiana , Pneumonia Bacteriana/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa